Overview

Keheala is a mobile health company that improves healthcare access and treatment outcomes for patients. By empowering patients with information, motivation and support, Keheala delivers the tools needed to overcome the non-medical drivers of disease that exist away from health facilities. Healthcare agencies are provided remote-monitoring capabilities and vital analytics to combat epidemics in resource-constrained environments.

Keheala has been covered in the New York Times and World Economic Forum.

How it works

Patients are enrolled in Keheala at a health care facility via their feature phone. They receive text messages to verify that they have to take their medication. If the patient does not respond, a trained Keheala team reaches out for support remotely.

Scoring

Keheala has been scored below according to it’s ability to serve the TB market for low- and middle-income countries (LMICs) along Fit for Purpose and Technical Specifications metrics. Note that higher scores equate to a greater ability to serve the market. For example, if a product scores well in the Provider Burden subcategory, that means that the burden for the provider is low.

For full descriptions of the sub-categories, see the 2021 DAT Market Landscape.

Fit for Purpose

Provider Burden100%
100%
Patient Burden50%
50%
Reach50%
50%
Barriers to Entry50%
50%
Accuracy0%
0%
Evidence100%
100%

Technical Specifications

Range100%
100%
Electricity0%
0%
Dosing History100%
100%
Data Integration100%
100%
Portability100%
100%
Reminders100%
100%
Automatic Reporting100%
100%

Advantages

  • Can be used from any feature phone or smartphone
  • No device to set up or maintain
  • Program is well-established for TB and in LMICs

Disadvantages

  • Relies on support center to help direct patients
  • Does not track adherence in real time
  • Requires consistent electricity access

Access

For more information on Keheala, please visit the Keheala website.

Menu